Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prince Pharmaceutical CoROCO:6935 -0.50%60 Interest Coverage is 17.92 as of Dec. 2025, which is 136% above its 10-year median of 7.59. GuruFocus rates ROCO:6935 with a GF Score™ of 60/100 and a GF Value™ of NT$42.11 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 687 Drug Manufacturers companies, Prince Pharmaceutical Co ranks worse than 51.82% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Prince Pharmaceutical Co's
Operating Income
for the
six
months ended in Dec. 2025 was NT$84 Mil. Prince Pharmaceutical Co's Interest Expense for the
six
months ended in Dec. 2025 was NT$-5 Mil.
Prince Pharmaceutical Co's interest coverage for the quarter that ended in Dec. 2025 was 17.92.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Prince Pharmaceutical Co's Interest Coverage or its related term are showing as below:
ROCO:6935'
s Interest Coverage Range Over the Past 10 Years
Min: 2.46 Med: 7.59 Max: 11.57
Current: 11.57
ROCO:6935's Interest Coverage is ranked worse than 51.82% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs ROCO:6935: 11.57
Prince Pharmaceutical Co (ROCO:6935) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Prince Pharmaceutical Co Interest Coverage Related Terms
Prince Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:6935 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Prince Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prince Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Prince Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Prince Pharmaceutical Co's Interest Coverage falls into.
Prince Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prince Pharmaceutical Co (ROCO:6935) has a Interest Coverage of 17.92 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Prince Pharmaceutical Co and its competitors. This is 136% above median its historical median of 7.59. Over the past decade, Prince Pharmaceutical Co's Interest Coverage has ranged from 2.46 to 11.57. According to the industry distribution chart, Prince Pharmaceutical Co ranks #356 out of 687 companies in the Drug Manufacturers industry, placing it in the top 51.8%.
Is Prince Pharmaceutical Co's Interest Coverage too high?
Prince Pharmaceutical Co's current Interest Coverage of 17.92 is 136% above median its 10-year median of 7.59. Over the past 10 years, this metric has ranged from a low of 2.46 to a high of 11.57. The Drug Manufacturers industry median Interest Coverage is 12.75. Prince Pharmaceutical Co's value of 17.92 is 40.5% above this industry median. Based on the distribution chart, Prince Pharmaceutical Co ranks #356 out of 687 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Prince Pharmaceutical Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prince Pharmaceutical Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Prince Pharmaceutical Co ranks #356 out of 687 companies for Interest Coverage. This places Prince Pharmaceutical Co in the lower half of its industry. The industry median Interest Coverage is 12.75. Prince Pharmaceutical Co's value of 17.92 is 40.5% above this benchmark. Historically, Prince Pharmaceutical Co's own Interest Coverage has ranged from 2.46 to 11.57 over the past decade. While the company's 10-year median is 7.59 vs. the industry median of 12.75, Prince Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prince Pharmaceutical Co's current Interest Coverage of 17.92 is 40.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Prince Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prince Pharmaceutical Co's current Interest Coverage is 17.92, which is 136% above median its own 10-year median of 7.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prince Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Prince Pharmaceutical Co (ROCO:6935) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$42.11, compared to a current price of NT$30.15 — trading 28.4% below its estimated fair value. The current Interest Coverage is 17.92, which is 136% above median its 10-year median of 7.59 and 40.5% above the Drug Manufacturers industry median of 12.75. Prince Pharmaceutical Co's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Prince Pharmaceutical Co (ROCO:6935), the current Interest Coverage is 17.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prince Pharmaceutical Co (ROCO:6935) Overvalued in 2026?
Based on GuruFocus' analysis, Prince Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$30.15 is trading 28.4% below its estimated GF Value™ of NT$42.11.
GuruFocus considers Prince Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for ROCO:6935:
Interest Coverage: 17.92 (136% above median its 10-year median of 7.59)
GF Value™: NT$42.11 vs. price of NT$30.15 (28.4% below fair value)
Industry Position: 40.5% above the Drug Manufacturers median (#356 of 687)
No single metric tells the full story. See the ROCO:6935 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.
60GF Score
Get the complete analysis for ROCO:6935
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6935 has been successfully added to your 
